Skip to content

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $5.1 Million Public Offering

Sichenzia Ross Ference LLP Represents Zynex, Inc. and Selling Shareholder in $55 Million Public Offering of Common Stock

Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock

Sichenzia Ross Ference LLP Represents Equillium, Inc. in $150 Million At-The-Market Offering Through Jeffries LLC 

Sichenzia Ross Ference LLP Represents H.C. Wainwright as Sales Agent in $7 Million At-The-Market Offering of BioPath Holdings

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6.43 Million Public Offering of Common Stock

CMF Wins Full Dismissal of FINRA Customer Case Against Broker and Broker-Dealer and Broker Wins Expungement from CRD

Two Bright Sides of Estate Planning During COVID-19

Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock

Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering 

CMF Wins FINRA Expungement of Customer Complaint for Registered Representative

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $6 Million Public Offering of Common Stock

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.4 Million Public Offering of Digital Ally, Inc. Common Stock

Founding Partner Marc J. Ross, Esq. Presents Legal Webinar on The Ethical Considerations for an Attorney Advising Clients Engaged In a Marijuana-Related Business

Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $5.1 Million Public Offering of Digital Ally, Inc. Common Stock

“Regulation Best Interest” Is Nearly Here. What Regulators Want to See. What Broker-Dealers Need to Know and Do.

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $8 Million Public Offering

Marc J. Ross, Esq. Presents a Legal Webinar Explaining the Confusion Surrounding Marijuana Law

Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $75 Million At-The-Market Offering

Sichenzia Ross Ference Founding Partner Marc J. Ross, Esq. to Present Legal Webinar on Federal Regulation Governing Marijuana-Related Businesses

Sichenzia Ross Ference LLP Represents Pareteum Corporation in $3.75 Million Offering of Series C Preferred Stock